Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists

European Journal of Immunology

Volumn 45, Issue 10, 2015, Pages 2798-2809

  Kreutz, Martin ^a   Bakdash, Ghaith ^a   Dolen, Yusuf ^a   Sköld, Annette E ^a,b   van Hout Kuijer, Maaike A ^a   de Vries, I Jolanda M ^a,c   Figdor, Carl G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adjuvants; Dendritic cells; Synergy; Toll like receptors; Type I IFN

Indexed keywords

ALPHA INTERFERON; CD8ALPHA ANTIGEN; INTERFERON; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR AGONIST; MEMBRANE PROTEIN; TLR3 PROTEIN, HUMAN; TLR3 PROTEIN, MOUSE; TLR7 PROTEIN, HUMAN; TLR7 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL SUBPOPULATION; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTERFERON PRODUCTION; MONOCYTE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; AGONISTS; ANIMAL; CYTOLOGY; IMMUNOLOGY;

ANIMALS; DENDRITIC CELLS; HUMANS; INTERFERON TYPE I; MEMBRANE GLYCOPROTEINS; MICE; TH1 CELLS; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 7;

EID: 84943197766     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545583     Document Type: Article

References (51)

1. Kapsenberg, M. L., Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003. 3: 984-993.
2. Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K. et al., Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004. 5: 1061-1068.
3. Alexopoulou, L., Holt, A. C., Medzhitov, R. and Flavell, R. A., Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001. 413: 732-738.
4. Diebold, S. S., Massacrier, C., Akira, S., Paturel, C., Morel, Y. and Reis, e Sousa, Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur. J. Immunol. 2006. 36: 3256-3267.
5. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T. et al., Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002. 3: 196-200.
6. Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G. et al., Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 2002. 3: 499.
7. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M. et al., A Toll-like receptor recognizes bacterial DNA. Nature 2000. 408: 740-745.
8. Reis, e Sousa, Toll-like receptors and dendritic cells: for whom the bug tolls. Semin. Immunol. 2004. 16: 27-34.
9. Bakdash, G., Schreurs, I., Schreibelt, G. and Tel, J., Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy. Expert Rev. Clin. Immunol. 2014. 10: 915-926.
10. Tel, J., Aarntzen, E. H., Baba, T., Schreibelt, G., Schulte, B. M., Benitez-Ribas, D., Boerman, O. C. et al., Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Cancer Res. 2013. 73: 1063-1075.
11. Kreutz, M., Giquel, B., Hu, Q., Abuknesha, R., Uematsu, S., Akira, S., Nestle, F. O. et al., Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity. PLoS One 2012. 7: e40208.
12. Tacken, P. J., Zeelenberg, I. S., Cruz, L. J., van Hout-Kuijer, M. A., vande Glind, G., Fokkink, R. G., Lambeck, A. J. et al., Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood 2011. 118: 6836-6844.
13. Tacken, P. J. and Figdor, C. G., Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines. Semin. Immunol. 2011. 23: 12-20.
14. Kreutz, M., Tacken, P. J. and Figdor, C. G., Targeting dendritic cells-why bother? Blood 2013. 121: 2836-2844.
15. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F. and Lanzavecchia, A., Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 2005. 6: 769-776.
16. Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E. E., Trinchieri, G. et al., A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 2005. 201: 1435-1446.
17. Cantisani, C., Lazic, T., Richetta, A. G., Clerico, R., Mattozzi, C. and Calvieri, S., Imiquimod 5% cream use in dermatology, side effects and recent patents. Recent Pat. Inflamm. Allergy Drug Discov. 2012. 6: 65-69.
18. Caskey, M., Lefebvre, F., Filali-Mouhim, A., Cameron, M. J., Goulet, J. P., Haddad, E. K., Breton, G. et al., Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J. Exp. Med. 2011. 208: 2357-2366.
19. Edwards, A. D., Diebold, S. S., Slack, E. M., Tomizawa, H., Hemmi, H., Kaisho, T., Akira, S. et al., Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 2003. 33: 827-833.
20. Kanneganti, T. D., Ozoren, N., Body-Malapel, M., Amer, A., Park, J. H., Franchi, L., Whitfield, J. et al., Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006. 440: 233-236.
21. Makela, S. M., Osterlund, P. and Julkunen, I., TLR ligands induce synergistic interferon-beta and interferon-lambda1 gene expression in human monocyte-derived dendritic cells. Mol. Immunol. 2011. 48: 505-515.
22. Bekeredjian-Ding, I. B., Wagner, M., Hornung, V., Giese, T., Schnurr, M., Endres, S. and Hartmann, G., Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 2005. 174: 4043-4050.
23. Thibault, D. L., Graham, K. L., Lee, L. Y., Balboni, I., Hertzog, P. J. and Utz, P. J., Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res. Ther. 2009. 11: R112.
24. Mohty, M., Vialle-Castellano, A., Nunes, J. A., Isnardon, D., Olive, D. and Gaugler, B., IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J. Immunol. 2003. 171: 3385-3393.
25. Jiao, Z., Bedoui, S., Brady, J. L., Walter, A., Chopin, M., Carrington, E. M., Sutherland, R. M. et al., The closely related CD103+ dendritic cells (DCs) and lymphoid-resident CD8+ DCs differ in their inflammatory functions. PLoS One 2014. 9: e91126.
26. Janeway, C. A., Jr., Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989. 54 Pt 1: 1-13.
27. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J. et al., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997. 27: 3135-3142.
28. Bonehill, A., Van Nuffel, A. M., Corthals, J., Tuyaerts, S., Heirman, C., Francois, V., Colau, D. et al., Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. Clin. Cancer Res. 2009. 15: 3366-3375.
29. Joffre, O., Nolte, M. A., Sporri, R. and Reis, e Sousa, Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 2009. 227: 234-247.
30. Hervas-Stubbs, S., Perez-Gracia, J. L., Rouzaut, A., Sanmamed, M. F., Le, B. A. and Melero, I., Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. 2011. 17: 2619-2627.
31. Lauterbach, H., Bathke, B., Gilles, S., Traidl-Hoffmann, C., Luber, C. A., Fejer, G., Freudenberg, M. A. et al., Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J. Exp. Med. 2010. 207: 2703-2717.
32. Fonteneau, J. F., Larsson, M., Beignon, A. S., McKenna, K., Dasilva, I., Amara, A., Liu, Y. J. et al., Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 2004. 78: 5223-5232.
33. Yoneyama, H., Matsuno, K., Toda, E., Nishiwaki, T., Matsuo, N., Nakano, A., Narumi, S. et al., Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 2005. 202: 425-435.
34. Piccioli, D., Sammicheli, C., Tavarini, S., Nuti, S., Frigimelica, E., Manetti, A. G., Nuccitelli, A. et al., Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation. Blood 2009. 113: 4232-4239.
35. Belz, G. T., Shortman, K., Bevan, M. J. and Heath, W. R., CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 2005. 175: 196-200.
36. Crespo, M. I., Zacca, E. R., Nunez, N. G., Ranocchia, R. P., Maccioni, M., Maletto, B. A., Pistoresi-Palencia, M. C. et al., TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8alpha+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface. J. Immunol. 2013. 190: 948-960.
37. Vasilakos, J. P. and Tomai, M. A., The use of Toll-like receptor 7/8 agonists as vaccine adjuvants. Expert Rev. Vaccines 2013. 12: 809-819.
38. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K. et al., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004. 5: 730-737.
39. Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S. et al., Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006. 441: 101-105.
40. Bauer, M., Redecke, V., Ellwart, J. W., Scherer, B., Kremer, J. P., Wagner, H. and Lipford, G. B., Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J. Immunol. 2001. 166: 5000-5007.
41. Loseke, S., Grage-Griebenow, E., Heine, H., Wagner, A., Akira, S., Bauer, S. and Bufe, A., In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells. Scand. J. Immunol. 2006. 63: 264-274.
42. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F. and Liu, Y. J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001. 194: 863-869.
43. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. and Lanzavecchia, A., Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001. 31: 3388-3393.
44. Schreibelt, G., Tel, J., Sliepen, K. H., Benitez-Ribas, D., Figdor, C. G., Adema, G. J. and de Vries, I. J., Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol. Immunother. 2010. 59: 1573-1582.
45. Tarhini, A. A., Gogas, H. and Kirkwood, J. M., IFN-alpha in the treatment of melanoma. J. Immunol. 2012. 189: 3789-3793.
46. Kirkwood, J. M. and Ernstoff, M. S., Interferons in the treatment of human cancer. J. Clin. Oncol. 1984. 2: 336-352.
47. Mocellin, S., Pasquali, S., Rossi, C. R. and Nitti, D., Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J. Natl. Cancer Inst. 2010. 102: 493-501.
48. Anandasabapathy, N., Victora, G. D., Meredith, M., Feder, R., Dong, B., Kluger, C., Yao, K. et al., Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J. Exp. Med. 2011. 208: 1695-1705.
49. Mogensen, K. E., Pyhala, L. and Cantell, K., Raising antibodies to human leukocyte interferon. Acta Pathol. Microbiol. Scand. B 1975. 83: 443-450.
50. Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M. et al., CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 2005. 6: 565-570.
51. Wang, X. and Seed, B., A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 2003. 31: e154.